Evidence map›Paper›PMID 21539919›Full record

ArticleProtein expression and purification2011

The variable detergent sensitivity of proteases that are utilized for recombinant protein affinity tag removal.

James M Vergis, Michael C Wiener

Abstract read
In one paragraph

Article in Protein expression and purification, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
5.2field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 46 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Purification of Membrane Proteins Overexpressed in Saccharomyces cerevisiae.Methods in molecular biology (Clifton, N.J.) · 2022
    Article
  5. The high-throughput production of membrane proteins.Emerging topics in life sciences · 2021
    Article
  6. Article
  7. Review
  8. Article
  9. Monoclonal Antibody HlyIIC‑15 to C-End Domain HlyIIRussian journal of bioorganic chemistry · 2020
    Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

James M VergisDepartment of Molecular Physiology and Biological Physics, University of Virginia, 480 Ray C. Hunt Drive, Charlottesville, VA 22908, USA.
Michael C Wiener
University of Virginia · US

Funding

Improved Methods: Membrane Protein Crystallization(RMI)R01GM075931 · NIGMS · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI WIENER, MICHAEL · 2005 to 2009
$1.4M
NIGMS NIH HHS 5R01 GM075931NIGMS NIH HHS R01 GM075931
6 · The paper itself

Abstract

Recombinant proteins typically include one or more affinity tags to facilitate purification and/or detection. Expression constructs with affinity tags often include an engineered protease site for tag removal. Like other enzymes, the activities of proteases can be affected by buffer conditions. The buffers used for integral membrane proteins contain detergents, which are required to maintain protein solubility. We examined the detergent sensitivity of six commonly-used proteases (enterokinase, factor Xa, human rhinovirus 3C protease, SUMOstar, tobacco etch virus protease, and thrombin) by use of a panel of 94 individual detergents. Thrombin activity was insensitive to the entire panel of detergents, thus suggesting it as the optimal choice for use with membrane proteins. Enterokinase and factor Xa were only affected by a small number of detergents, making them good choices as well.

Indexed as

Chromatography, AffinityDetergentsElectrophoresis, Polyacrylamide GelMembrane ProteinsPeptide HydrolasesProtein StabilityRecombinant Fusion ProteinsDetergentsMembrane ProteinsPeptide HydrolasesRecombinant Fusion Proteins

Identifiers

PMID21539919
PMCPMC3130611
OpenAlexW2118611194

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.